Find Clinical Trial


Trial Status:
Gender:
Condition:

CLINICAL TRIALS

Previous Page        Next Page

A Dose-Blind, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of Two Doses of BG00012 Monotherapy in Subjects with Relapsing-Remitting Multiple Sclerosis. The primary objective of this study…

CONDITION: Neurological

TRIAL STATUS: Active, not recruiting

GENDER: Both males and females

AGE GROUP: 18 years and above


Previous Page        Next Page